Literature DB >> 20379957

Cucurbitane-type triterpenoids from Momordica charantia.

Jun Ma1, Paul Whittaker, Amy C Keller, Eugene P Mazzola, Rahul S Pawar, Kevin D White, John H Callahan, Edward J Kennelly, Alexander J Krynitsky, Jeanne I Rader.   

Abstract

One new cucurbitane-type triterpenoid glycoside, momordicoside U (1), together with five known cucurbitane-type triterpenoids and related glycosides, 3β,7 β,25-trihydroxycucurbita-5,23 (E)-dien-19-al (2), momordicine I (3), momordicine II (4), 3-hydroxycucurbita-5,24-dien-19-al-7,23-di-O-β-glucopyranoside (5), and kuguaglycoside G (6), were isolated from the whole plant of Momordica charantia. Their structures were determined by chemical and spectroscopic methods. Momordicoside U (1) was evaluated for insulin secretion activity in an in vitro insulin secretion assay and displayed moderate activity. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20379957     DOI: 10.1055/s-0030-1249807

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  14 in total

1.  Sesquiterpenoid tropolone glycosides from Liriosma ovata.

Authors:  Jun Ma; Rahul S Pawar; Erich Grundel; Eugene P Mazzola; Clark D Ridge; Takashi Masaoka; Stuart F J Le Grice; Jennifer Wilson; John A Beutler; Alexander J Krynitsky
Journal:  J Nat Prod       Date:  2015-01-14       Impact factor: 4.050

2.  Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro.

Authors:  Amy C Keller; Jun Ma; Adam Kavalier; Kan He; Anne-Marie B Brillantes; Edward J Kennelly
Journal:  Phytomedicine       Date:  2011-11-30       Impact factor: 5.340

Review 3.  Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.

Authors:  Komal Raina; Dileep Kumar; Rajesh Agarwal
Journal:  Semin Cancer Biol       Date:  2016-07-21       Impact factor: 15.707

4.  Medicinal plants used for treatment of diabetes by the Marakh sect of the Garo tribe living in Mymensingh district, Bangladesh.

Authors:  Mohammed Rahmatullah; Md Nur Kabidul Azam; Zubaida Khatun; Syeda Seraj; Farhana Islam; Md Atiqur Rahman; Sharmin Jahan; Md Shah Aziz
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-04-02

5.  Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review.

Authors:  Zeinab Nazarian-Samani; Robert D E Sewell; Zahra Lorigooini; Mahmoud Rafieian-Kopaei
Journal:  Curr Diab Rep       Date:  2018-08-13       Impact factor: 4.810

6.  Wild bitter gourd improves metabolic syndrome: a preliminary dietary supplementation trial.

Authors:  Chung-Huang Tsai; Emily Chin-Fun Chen; Hsin-Sheng Tsay; Ching-jang Huang
Journal:  Nutr J       Date:  2012-01-13       Impact factor: 3.271

Review 7.  Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome.

Authors:  Md Ashraful Alam; Riaz Uddin; Nusrat Subhan; Md Mahbubur Rahman; Preeti Jain; Hasan Mahmud Reza
Journal:  J Lipids       Date:  2015-01-12

8.  Inhibitory Effects of Momordicine I on High-Glucose-Induced Cell Proliferation and Collagen Synthesis in Rat Cardiac Fibroblasts.

Authors:  Po-Yuan Chen; Neng-Lang Shih; Wen-Rui Hao; Chun-Chao Chen; Ju-Chi Liu; Li-Chin Sung
Journal:  Oxid Med Cell Longev       Date:  2018-10-08       Impact factor: 6.543

Review 9.  Phytotherapy in the Management of Diabetes: A Review.

Authors:  Paolo Governa; Giulia Baini; Vittoria Borgonetti; Giulia Cettolin; Daniela Giachetti; Anna Rosa Magnano; Elisabetta Miraldi; Marco Biagi
Journal:  Molecules       Date:  2018-01-04       Impact factor: 4.411

10.  Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.

Authors:  Emanuel L Peter; Serawit Deyno; Andrew Mtewa; Félicien Mushagalusa Kasali; Prakash B Nagendrappa; Duncan Sesaazi; Casim Umba Tolo; Patrick Engeu Ogwang
Journal:  Syst Rev       Date:  2018-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.